Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06027164 · ClinicalTrials.gov registry record
Kosmos Trio and Ejection Fraction Pivotal Study
A clinical trial of Cardiac Disease, sponsored by EchoNous.
- Completed
- Registry status
- 153
- Enrollment target
- 1
- Study location
NCT06027164 is a study of Cardiac Disease that has completed, run by EchoNous. The registered enrollment target is 153 participants, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06027164, a study of Cardiac Disease, has completed, sponsored by EchoNous.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-group, observational study which will involve obtaining two echo scans of recruited patients. All recruited patients will undergo echo scans by both novice users (nurses) and experts (echo sonographers). Image quality between novices and experts as well as the ability to calculate LVEF from novice and expert scans and the quality of the LVEF calculated via KOSMOS-EF compared to LVEF calculations by expert cardiologists will occur in post-hoc Echo image analysis
Conditions Studied
Interventions
- DEVICE Portable Ultrasound System
Study Locations (1)
Michigan
- Revival Research Institute LLC - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2024-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06027164
The ClinicalTrials.gov registry entry for NCT06027164 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower). The listed sponsor is EchoNous, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Portable Ultrasound System is the first listed.
NCT06027164 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06027164 about?
NCT06027164 is a clinical study titled "Kosmos Trio and Ejection Fraction Pivotal Study". This is a single-group, observational study which will involve obtaining two echo scans of recruited patients. All recruited patients will undergo echo scans by both novice users (nurses) and experts (echo sonographers). Image quality between novices and experts as well as the ability to calculate L...
What is the current status of trial NCT06027164?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2023-08-04. Estimated completion is 2024-05-16.
What conditions does trial NCT06027164 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT06027164?
The interventions under investigation include: Portable Ultrasound System (DEVICE).
Who is sponsoring clinical trial NCT06027164?
This trial is sponsored by EchoNous, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06027164 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.